Bench-to-bedside review: Is there a place for epinephrine in septic shock?

Critical Care

Volumn 9, Issue 6, 2005, Pages 561-565

  Levy, Bruno ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOPAMINE; HYPERTENSIVE FACTOR; LACTIC ACID; NORADRENALIN; OXYGEN; VASOPRESSIN; DOBUTAMINE; PROPRANOLOL;

AEROBIC METABOLISM; ANTICOAGULATION; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG USE; GLYCOLYSIS; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HEPATIC VEIN; HUMAN; HYPERGLYCEMIA; HYPERKINESIA; HYPERLACTATEMIA; IMMUNOMODULATION; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; MEAN ARTERIAL PRESSURE; MORBIDITY; MORTALITY; NONHUMAN; OXYGEN SATURATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEPTIC SHOCK; SPLANCHNIC BLOOD FLOW; TONOMETRY; VENOUS OXYGEN TENSION; VOLUNTEER; APOPTOSIS; ARTERIAL PRESSURE; BLOOD CARBON DIOXIDE TENSION; CARDIOTOXICITY; COST BENEFIT ANALYSIS; DRUG POTENCY; DRUG PREFERENCE; MONOTHERAPY; SIDE EFFECT;

ANIMALS; ANTICOAGULANTS; BLOOD GAS ANALYSIS; EPINEPHRINE; HEMODYNAMIC PROCESSES; HUMANS; IMMUNOLOGIC FACTORS; METABOLIC DISEASES; SHOCK, SEPTIC; SPLANCHNIC CIRCULATION; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 31744441411     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc3901     Document Type: Review

References (28)

1. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
2. Rudis MI, Basha MA, Zarowitz BJ: Is it time to reposition vasopressors and inotropes in sepsis? Crit Care Med 1996, 24: 525-537.
3. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, et al.: Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004, 32:1928-1948.
4. Bearn AG, Billing B, Sherlock S: The effect of adrenaline and noradrenaline on hepatic blood flow and splanchnic carbohydrate metabolism in man. J Physiol 1951, 115:430-441.
5. Ensinger H, Weichel T, Lindner KH, Grunert A, Georgieff M: Are the effects of noradrenaline, adrenaline and dopamine infusions on VO2 and metabolism transient? Intensive Care Med 1995, 21:50-56.
6. Wilson W, Lipman J, Scribante J, Kobilski S, Lee C, Krause P, Cooper J, Barr J: Septic shock: does adrenaline have a role as a first-line inotropic agent? Anaesth Intensive Care 1992, 20: 470-474.
7. Moran JL, O'Fathartaigh MS, Peisach AR, Chapman MJ, Leppard P: Epinephrine as an inotropic agent in septic shock: a dose-profile analysis. Crit Care Med 1993, 21:70-77.
8. Le Tulzo Y, Seguin P, Gacouin A, Camus C, Suprin E, Jouannic I, Thomas R: Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: a preliminary descriptive study. Intensive Care Med 1997, 23:664-670.
9. Levy B, Bollaert PE, Charpentier C, Nace L, Audibert G, Bauer P, Nabet P, Larcan A: Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 1997, 23:282-287.
10. Day NP, Phu NH, Bethell DP, Mai NT, Chau TT, Hien TT, White NJ: The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet 1996, 348:219-223.
11. Silverman HJ, Penaranda R, Orens JB, Lee NH: Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines. Crit Care Med 1993, 21:31-39.
12. Levy B, Mansart A, Bollaert PE, Franck P, Mallie JP: Effects of epinephrine and norepinephrine on hemodynamics, oxidative metabolism, and organ energetics in endotoxemic rats. Intensive Care Med 2003, 29:292-300.
13. James JH, Luchette FA, McCarter FD, Fischer JE: Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet 1999, 354:505-508.
14. Levy B, Gibot S, Franck P, Cravoisy A, Bollaert PE: Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet 2005, 365:871-875.
15. Levy B, Gawalkiewicz P, Vallet B, Briancon S, Nace L, Bollaert PE: Gastric capnometry with air-automated tonometry predicts outcome in critically ill patients. Crit Care Med 2003, 31: 474-480.
16. Chapman MV, Mythen MG, Webb AR, Vincent JL: Report from the meeting: Gastrointestinal Tonometry: State of the Art. 22nd-23rd May 1998, London, UK. Intensive Care Med 2000, 26:613-622.
17. Duranteau J, Sitbon P, Teboul JL, Vicaut E, Anguel N, Richard C, Samii K: Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 1999, 27:893-900.
18. De Backer D, Creteur J, Silva E, Vincent JL: Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 2003, 31:1659-1667.
19. Meier-Hellmann A, Reinhart K, Bredle DL, Specht M, Spies CD, Hannemann L: Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 1997, 25:399-404.
20. Levy B, Bollaert PE, Lucchelli JP, Sadoune LO, Nace L, Larcan A: Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock. Crit Care Med 1997, 25:1649-1654.
21. Seguin P, Bellissant E, Le Tulzo Y, Laviolle B, Lessard Y, Thomas R, Malledant Y: Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther 2002, 71:381-388.
22. Van der Poll T, Lowry SF: Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10. Am J Physiol 1997, 273:R1885-1890.
23. Oberbeck R, Schmitz D, Wilsenack K, Schuler M, Pehle B, Schedlowski M, Exton MS: Adrenergic modulation of survival and cellular immune functions during polymicrobial sepsis. Neuroimmunomodulation 2004, 11:214-223.
24. Oberbeck R: Therapeutic implications of immune-endocrine interactions in the critically ill patients. Curr Drug Targets Immune Endocr Metabol Disord 2004, 4:129-139.
25. van der Poll T, Levi M, Dentener M, Jansen PM, Coyle SM, Braxton CC, Buurman WA, Hack CE, ten Cate JW, Lowry SF: Epinephrine exerts anticoagulant effects during human endotoxemia. J Exp Med 1997, 185:1143-1148.
26. Mullner M, Urbanek B, Havel C, Losert H, Waechter F, Gamper G: Vasopressors for shock. Cochrane Database Syst Rev 2004, CD003709.
27. Annane D, Vignon P, Bollaert PE, Charpentier C, Martin C, Troche G, Ricard JD, Nitenberg G, Bellissant E, for the CATS study group: Norepinephrine plus dobutamine versus epinephrine alone for the management of septic shock. Intensive Care Med 2005, 31:S1-S18.
28. Levy B: Epinephrine in septic shock: Dr. Jekyll or Mr. Hyde? Crit Care Med 2003, 31:1866-1867.